Browse past events in Calendar View

Loading Events

« All Events

  • This event has passed.

Migraine Management in Women

October 15 @ 12:00 am - 11:30 pm

Sex Differences in Migraine Management
Addressing Cycles of Care

2.0 AMA PRA Category 1 Credits™
This Enduring Module is Available for One Year
June 16, 2021 – June 15, 2022


Migraine is the sixth most prevalent disease worldwide, including 28 million women. You might call it a sex- and gender-specific condition since migraine affects women 3 to 1 to men, with changing effects at different stages of a woman’s life. It is particularly burdensome among young and middle-aged women, and is often discounted as “just a headache.” When, in fact, migraine is highly disabling and ranks second in terms of years of life lived with disability, women in medicine should be prepared to recognize and respond to complaints from women so treatment and long-term management can be offered.
Gretchen E. Tietjen, MD, Distinguished University Professor of Neurology Emerita University of Toledo College of Medicine & Life Science
Learning Objectives 
• Address the influences of environmental triggers, genetic predisposition, and sex differences in the development of this neurological, chronic migraine condition
• Describe the relationship between migraine and comorbid conditions that commonly occur in women
• Describe risks of migraine during different stages of a woman’s life, particularly during the menopausal transition
• Consider the efficacy of preventive strategies and review published guidance on pharmacologic therapies, non-pharmacologic management, and combination approaches.

Enduring material will be accessible from June 16, 2021 to June 15, 2022, to advance quality clinical care of migraines in women as part of National Headache and Migraine Awareness Month in June and throughout the year.

Migraine Management is available as an enduring clinical education model.
Registrants will receive a link to the recording, syllabus, and presentation PowerPoint

To Claim CME Credit, Click HERE


Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Indiana University School of Medicine and the American Medical Women’s Association. Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Indiana University School of Medicine designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate
with the extent of their participation in the activity.

Faculty Disclosures

Indiana University School of Medicine (IUSM) policy ensures that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that IUSM may identify and resolve any conflicts of interest prior to the activity. All educational programs sponsored by Indiana University School of Medicine must demonstrate balance, independence, objectivity, and scientific rigor.

There are no relevant financial relationships with a commercial interest for anyone who was in control of the content of this activity, except:  Gretchen Tietjen, MD, who  has disclosed that her spouse has stock ownership in from Johnson & Johnson.  All conflicts have been resolved.

Indiana University School of Medicine (IUSM) defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Program Support

This activity is supported by educational funding provided by Amgen and Lilly.


October 15
12:00 am - 11:30 pm
Event Category:
Event Tags:
, , ,

Browse past events in Calendar View